.Pharmacolibrary.Drugs.G_GenitoUrinarySystemAndSexHormones.G03D_Progestogens.G03DC31_Methylestrenolone.Methylestrenolone .Pharmacolibrary.Drugs.G_GenitoUrinarySystemAndSexHormones.G03D_Progestogens.G03DC31_Methylestrenolone.Methylestrenolone| name: | Methylestrenolone | |
| ATC code: | G03DC31 | route: | orally |
| compartments: | 1 | |
| dosage: | 10 | mg |
| volume of distribution: | 1 | L |
| clearance: | 10 | L/hr |
| other parameters in model implementation | ||
Methylestrenolone is a synthetic, orally active anabolic–androgenic steroid (AAS) derived from 17α-methylation of nandrolone. It was developed in the 1960s for potential use as a performance-enhancing substance, but it was never marketed or approved for medical use due to safety concerns and high hepatotoxicity.
No published human pharmacokinetic studies available; the following parameters are estimated based on chemical similarity to other 17α-methylated anabolic steroids such as methyltestosterone.